SNIFF 120: Study of Nasal Insulin to Fight Forgetfulness (120 Days)

Completed · Phase 2 · Has a placebo group

Conditions studied: Mild Cognitive Impairment, Alzheimer's Disease

In brief

The purpose of this study is to find out if insulin, when administered as a "nasal spray" into the nasal passages, improves memory in adults with mild cognitive impairment (MCI) or Alzheimer's disease.

Key facts

Study ID
NCT00438568
Run by
University of Washington
People needed
173
Starts
2006-06-01
Expected to finish
2011-12-01
Last updated by the study team
2012-09-14

Who can join

Age: 55 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.